SLC5A5 and cancer: Second, we have used human NIS in this work (because of human cancer cells/xenograft model) but in spite of 83.6% sequence identity between human and mouse NIS orthologs (cf.https://www.ncbi.nlm.nih.gov/homologene), it cannot be ruled out that human NIS elicits an immune response in fully immunocompetent mice.